Cue Biopharma, Inc.
Biotechnology · BOSTON, MA
BiotechnologySEC Form D
Cue Biopharma, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 14, 2026, reporting $29,999,992 raised.
Incorporated in Delaware and based in BOSTON, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Cue Biopharma, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Shao-Lee LinExecutive Officer · Director
- Colin SandercockExecutive Officer
- Daniel BakerExecutive Officer
- Pasha SarrafDirector
- Frank MorichDirector
- Peter KienerDirector
- Patrick VerheyenDirector
- Pamela D. GarzoneDirector
- Jill M. BroadfootDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised